Yet, A-769662 was also shown to have beneficial effects on both hepatic steatosis and insulin resistance, thus emphasizing the potential therapeutic implications for AMPK activation in anti-IL-6 responsive RA patients and associated metabolic syndrome [34]. The gene discussed is PRKAA1; the disease is metabolic syndrome.